A 92-year-old gentleman presented with sensation of thumping in the chest. Carelink transmission revealed that he received 15 shocks from his Medtronic Protecta XT DR implantable cardiac defibrillator (ICD) in a 24-hour period. He had ischemic cardiomyopathy and received a dual chamber ICD 12 years ago after an episode of monomorphic ventricular tachycardia (VT). Amiodarone was discontinued due to interstitial lung disease and since then he had been on metoprolol 50 mg BID. Baseline ECG showed normal sinus rhythm. Subject had previous VT episodes which were terminated with anti-tachycardia pacing (ATP). He had not had a shock from his device over the past 12 months. Figure 1 This observation excluded atrioventricular tachycardia (AVRT). It was less likely VT with 1 to 1 retrograde conduction to atrium as it would be highly unlikely that atrial TCL remains unperturbed during ventricular overdrive pacing. There was no evidence of entrainment or resetting of the A from the V during ATP. At the end of each ATP, the subsequent three VV intervals were markedly slower than 480 ms, demonstrating absence of entrainment. These reproducible observations (8 times in all) helped with the conclusion that this tachycardia was highly unlikely to be macro re-entrant VT, AVRT, or atrioventricular nodal re-entrant tachycardia (AVNRT). These
| CASE
A 92-year-old gentleman presented with sensation of thumping in the chest. Carelink transmission revealed that he received 15 shocks from his Medtronic Protecta XT DR implantable cardiac defibrillator (ICD) in a 24-hour period. He had ischemic cardiomyopathy and received a dual chamber ICD 12 years ago after an episode of monomorphic ventricular tachycardia (VT). Amiodarone was discontinued due to interstitial lung disease and since then he had been on metoprolol 50 mg BID. Baseline ECG showed normal sinus rhythm. Subject had previous VT episodes which were terminated with anti-tachycardia pacing (ATP). He had not had a shock from his device over the past 12 months. This observation excluded atrioventricular tachycardia (AVRT). It was less likely VT with 1 to 1 retrograde conduction to atrium as it would be highly unlikely that atrial TCL remains unperturbed during ventricular overdrive pacing. There was no evidence of entrainment or resetting of the A from the V during ATP. At the end of each ATP, the subsequent three VV intervals were markedly slower than 480 ms, demonstrating absence of entrainment. These reproducible observations (8 times in all) helped with the conclusion that this tachycardia was highly unlikely to be macro re-entrant VT, AVRT, or atrioventricular nodal re-entrant tachycardia (AVNRT). These
observations would narrow our differential diagnosis to that of atrial tachycardia (AT) or sinus tachycardia (ST).
| Interpreting the intracardiac electrocardiogram
Figure 2 showed intracardiac electrocardiograms (EGM) from the right atrium and right ventricular leads. In the first row, marker channels were denoted by "AS" which represented sensed atrial activity by the device. However, in the same first row, there was loss of "AS" when the amplitude of the atrial EGM became smaller. This corresponded with the interval plot in Figure 1 when AA TCL suddenly increased from 490 to 1480 ms, confirming atrial undersensing. This intermittent loss of atrial sensing was repeated in the 2nd row and during the rest of the tachycardia event.
At the bottom of both rows in Figure 2 , marker channel annotation "ST" indicated that the device algorithm initially diagnosed the tachycardia as sinus tachycardia. Unfortunately, later in the tachycardia, there were 16 consecutive intervals in the programmed VT zone F I G U R E 2 Intracardiac electrocardiogram (EGM) from the right atrium and right ventricular leads as derived the from the implantable cardioverter deibrillator F I G U R E 1 Interval plot tracing from the recorded event on the implatable cardioverter defibrillator with more V EGMs than A EGMs, due to atrial undersensing, leading to reclassification of tachycardia as VT and initiation of programmed therapy.
We observed from device EGM that the atrial EGM during tachycardia was of the same morphology as the atrial EGM post termination of tachycardia. This confirmed that the algorithm was correct in initially classifying the tachycardia as sinus tachycardia, but due to atrial undersensing, it was subsequently misclassified as VT and the subject received inappropriate therapy. However, after the tachycardia slowed down it was deemed to have terminated by the device and no further therapy was delivered.
| Correlating clinical information with device interrogation findings
The subject was found to have severe anemia, which resulted in ST.
VT zone was previously extended downwards due to concerns of amiodarone therapy resulting in slow VT. This resulted in overlap between VT detection zone and subject's maximum predicted sinus rates. Discontinuation of amiodarone, with resultant loss of betablocking action, and severe anemia resulted in ST that was misinterpreted as VT due to atrial undersensing. It is important to remember that beta-blockers and device reprogramming should be considered while discontinuing amiodarone.
| Interventions
We lowered atrial lead sensitivity from 0.9 to 0.3 mV to avoid undersensing in atrial lead. We stretched VT detection from 16 to 28 consecutive intervals and raised VT zone TCL from 530 ms to 490 ms to avoid inappropriate therapies in the VT zone. In this episode, there was intermittent atrial undersensing that triggered VT detection. Stretching detection interval reduces the chance of enough consecutive under sensed atrial EGMs to fulfill the VT criteria. We switched off shock therapies in VT zone as VT at this relative slow rate is unlikely to be hemodynamically significant thereby reducing the chance of inappropriate shocks. The subject also received appropriate therapy to correct anemia.
| CONCLUSION
The interval plot is a useful tool to allow physicians to interpret events at a glance. Accurate interpretation of the intra cardiac EGM would also be necessary to allow us to make an accurate diagnosis.
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